US Patent Application 20090304799 - NANOEMULSION INFLUENZA VACCINE
InventorsAssigneeUS Classes424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/199.1, Recombinant virus encoding one or more heterologous proteins or fragments thereof424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)435/252.1, Bacteria or actinomycetales; media therefor435/238, By chemical treatment435/254.1, Fungi435/258.1, Protozoa, media therefor977/773, Nanoparticle (structure having three dimensions of 100 nm or less)977/906Drug deliveryAttorney, Agent or FirmInternational ClassesA61K 9/14A61K 39/145 C12N 1/20 C12N 7/06 C12N 1/10 C12N 1/14 A61P 37/04 Abstract textThe present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein. |
| ||||||||||||||
